Great board review resource getting so much information into one book!
24.06.2025 18:34 — 👍 2 🔁 0 💬 1 📌 0@handleyg.bsky.social
Transplant & Oncology ID at MD Anderson Cancer Center @mdanderson.bsky.social | UAB Heersink → Ochsner Clinic → UTHealth/MDACC | #IDSky #TxID | Views are my own
Great board review resource getting so much information into one book!
24.06.2025 18:34 — 👍 2 🔁 0 💬 1 📌 0In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine had no signs of relapse after three years.
Dr. Vinod Balachandran from @mskcancercenter.bsky.social joins us to discuss the results and what they could mean for cancer treatment.
#IDSky #AMR #PharmSky @idsainfo.bsky.social
🚨 On December 13, 2024, ASM and IDSA announced partnership to an annual conference on antimicrobial resistance starting in 2026! Cesar Arias, M.D., Ph.D., M.S., and Greg Moeck, Ph.D., are Co-Chairs of the Program Committee.
asm.org/Press-Releas...
We are thrilled to announce our 2025 USF ID Fellows! Welcome to USF ID family! #UStayForever #USF #GoBulls #IDSky #FellowshipMatch #Match #usfid
12.12.2024 17:07 — 👍 8 🔁 1 💬 0 📌 3Voting for the official 2025 #PanCANPurpleStride T-Shirt design has begun! 💜
To cast your vote, register for your local event at purplestride.org! Then, you'll receive an email to submit your pick. 📧 Voting ends on Wednesday, 12/18! 📅 Once you vote, make sure to raise $50+ to secure your shirt! ✅
The annual #PanCANPurpleStride T-shirt is a BIG deal! 💜 Our Founder, Pam Acosta Marquardt, even had this special blanket created from all her past T-shirts! 😍
Starting TOMORROW, all registered Striders can cast their vote for their favorite 2025 T-shirt design 🗳 Register now at purplestride.org!
Beyond happy with our match and our new class of fellows at UTHealth Houston
07.12.2024 17:22 — 👍 9 🔁 1 💬 0 📌 0Had a great chat with Tori Whitacre Martonicz from Infection Control Today on some of our recent research with genomic surveillance for healthcare outbreaks ⤵️
“Genomic Surveillance A New Frontier in Health Care Outbreak Detection”
#IDSky #MedSky
www.infectioncontroltoday.com/view/genomic...
A photo of Fred Hutch Cancer Center in Seattle, with the Arnold buildling and "the Vessel" sculpture in front.
Mount Rainer surrounded by a field of wildflowers
📢 Brand new ID faculty position just posted @fredhutch.bsky.social in Seattle. Join our ID group that studies infections in immunocompromised hosts. The Emerald city has great academics, phenomenal facilities, outstanding collaborators - all in amazing surroundings.
apply.interfolio.com/159913
Critical point for Infection Control. Also the difference between HZ and DZ can be very subtle and changes over time
23.11.2024 12:50 — 👍 3 🔁 1 💬 0 📌 0New practice guideline from NCCN this month including prophylaxis and CAR T-cell therapy updates. Very handy for clinicians and researchers!
pubmed.ncbi.nlm.nih.gov/39536464/
New virtual meeting for Immunocompromised Host Society: Addressing the Landscape of CMV Management in Transplant Recipients. Free to members or $25 plus a free membership for those not already members!
Forward on to your residents, fellows, grad students, and international colleagues
#TxID #CMV
Good morning! It’s #AntibioticStewardshipWeek! Prompting awareness for the sensible use of antibiotics and using PO ABx when you can. 😊💊👨🏻⚕️ #IDSky #AMR
18.11.2024 13:02 — 👍 27 🔁 5 💬 1 📌 0Cementing the professional legitimacy of 🦋
We now have the journals on #MedSky & #IDSky
@jamacurrent.bsky.social
@bmj.com
@cmicomms.bsky.social (first one?)
@eurosurveillance.bsky.social
@cidjournal.bsky.social
@ofidjournal.bsky.social
@thejhi.bsky.social
@jclinical-invest.bsky.social
Fantastic discussion yesterday with leaders in the field about NIH funding, clinical trials, national society/guidelines. Great for early career physicians and looking forward to the next meeting
16.11.2024 13:52 — 👍 2 🔁 0 💬 0 📌 0We want to thank our expert panel for leading our first seminar this year "Building a Research Portfolio in Transplant ID!"
Look out for our upcoming series in the new year and message us if interested!!
1) Hepatitis B in SOT
2) Challenging Cases in TxID
3) CMV and SCT
Both letermovir & maribavir can be perpetrator or victim of a drug–drug interaction
🆕️🔥 #CPK
Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir & Maribavir: Guidance for Clinicians #idsky
✨️tables✨️ #bookmark
link.springer.com/article/10.1...
ID is a crucial specialty in medicine, yet applications for fellowship have declined.
In CIDJournal, Collin Telchik, MD, MPH, & colleagues evaluate interest in ID among med students & identify factors associated with interest/disinterest in ID @idsainfo.bsky.social
academic.oup.com/cid/advance-...